US-based MicroAire Surgical Instruments has acquired NEOSYAD, a developer of technology for adipose tissue engineering. France-based NEOSYAD recently gained CE marking under the European Union’s ...

A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader. Susan Dillon has stepped down as president and CEO of Aro Biotherapeutics. She ...

Expert Review of Precision Medicine and Drug Development, Current approaches and future perspectives on strategies for the development of personalized tissue engineering therapies Computational and ...

This is common. Those of us in research routinely store patient samples — blood, fluids, tissue, scrapings, and other ...

Despite the failure of an eczema trial in December, Q32 Bio is sticking with bempikibart. But a phase 2-stage complement inhibitor and a number of the biotech’s “valued colleagues” won’t be so lucky.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Biotechnology Market OverviewThe Biotechnology Market report delivers crucial insights into the market's growth trajectory ...

"MicroAire closes deal to acquire adipose tissue biotech NEOSYAD" was originally created and published by Medical Device Network, a GlobalData owned brand.